Portfolio concentration
As of March 31, 2026 · N-PORT
Holdings
82
Top-10 weight
41.51%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
37
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
998.4
Holdings
As of March 31, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | LILLY ELI and CO | — | 14,751 | $13.57M | 9.14% |
| 2 | JOHNSON&JOHNSON | — | 35,303 | $8.63M | 5.81% |
| 3 | AstraZeneca PLC ORD USD0.25 | AZN LN | 32,828 | $6.47M | 4.36% |
| 4 | GILEAD SCIENCES INC | — | 43,847 | $6.11M | 4.12% |
| 5 | ABBVIE INC | — | 25,391 | $5.52M | 3.72% |
| 6 | CENCORA INC | — | 17,242 | $5.42M | 3.65% |
| 7 | MCKESSON CORP | — | 6,187 | $5.35M | 3.61% |
| 8 | ARGENX SE SPONSORED ADR | — | 6,892 | $5.03M | 3.39% |
| 9 | Invesco Private Prime Fund | — | 4,282,136 | $4.28M | 2.89% |
| 10 | Invesco Treasury Portfolio, Institutional Class | — | 3,680,431 | $3.68M | 2.48% |
| 11 | MERCK & CO | — | 27,966 | $3.36M | 2.27% |
| 12 | WELLTOWER INC | — | 15,671 | $3.10M | 2.09% |
| 13 | HCA HEALTHCARE INC | — | 6,432 | $3.04M | 2.05% |
| 14 | VERTEX PHARMACEUTICALS INC | — | 6,623 | $2.96M | 1.99% |
| 15 | ROYALTY PHARMA-A | — | 57,339 | $2.75M | 1.85% |
| 16 | BRIGHTSPRING HEALTH SERVICES INC | — | 62,746 | $2.67M | 1.80% |
| 17 | INSMED INC | — | 15,670 | $2.56M | 1.73% |
| 18 | CARDINAL HEALTH INC | — | 11,823 | $2.50M | 1.68% |
| 19 | REGENERON PHARMACEUTICALS INC | — | 3,228 | $2.49M | 1.68% |
| 20 | THERMO FISHER SCIENTIFIC INC | — | 4,714 | $2.32M | 1.56% |
| 21 | UCB SA | — | 7,580 | $2.28M | 1.54% |
| 22 | GUARDANT HEALTH INC | — | 24,692 | $2.28M | 1.54% |
| 23 | NATERA INC | — | 11,191 | $2.24M | 1.51% |
| 24 | IDEXX LABS INC | — | 3,792 | $2.13M | 1.44% |
| 25 | BRIDGEBIO PHARMA INC | — | 28,134 | $2.09M | 1.41% |
| 26 | UNITEDHEALTH GRP | — | 7,708 | $2.09M | 1.41% |
| 27 | AXSOME THERAPEUTICS INC | — | 11,411 | $1.93M | 1.30% |
| 28 | Invesco Government & Agency Portfolio, Institutional Class | — | 1,919,183 | $1.92M | 1.29% |
| 29 | INTUITIVE SURGICAL INC | — | 3,973 | $1.83M | 1.23% |
| 30 | UNITED THERAPEUTICS CORP DEL | — | 2,998 | $1.78M | 1.20% |
| 31 | SANDOZ GRP. AG | SDZXF | 22,014 | $1.72M | 1.16% |
| 32 | METTLER-TOLEDO INTL INC | — | 1,363 | $1.72M | 1.16% |
| 33 | EDWARDS LIFESCIENCES CORP | — | 20,667 | $1.66M | 1.12% |
| 34 | Invesco Private Government Fund | — | 1,653,340 | $1.65M | 1.11% |
| 35 | BOSTON SCIENTIFIC CORP | — | 26,142 | $1.64M | 1.11% |
| 36 | Ascendis Pharma A/S | — | 7,074 | $1.62M | 1.09% |
| 37 | TENET HEALTHCARE CORP | — | 8,514 | $1.61M | 1.08% |
| 38 | ENCOMPASS HEALTH CORP | — | 15,280 | $1.48M | 1.00% |
| 39 | MADRIGAL PHARMACEUTICALS INC | — | 2,753 | $1.44M | 0.97% |
| 40 | PROTAGONIST THERAPEUTICS INC | — | 13,525 | $1.43M | 0.96% |
| 41 | CVS HEALTH CORP | — | 19,815 | $1.42M | 0.96% |
| 42 | MEDLINE INC-A | — | 29,508 | $1.31M | 0.88% |
| 43 | HALOZYME THERAPEUTICS INC | — | 20,180 | $1.30M | 0.88% |
| 44 | GALDERMA GRP. AG | GDERF | 6,470 | $1.27M | 0.86% |
| 45 | LONZA GRP. AG | LZAGF | 1,915 | $1.23M | 0.83% |
| 46 | LIGAND PHARMACEUTICALS | — | 5,939 | $1.19M | 0.80% |
| 47 | IONIS PHARMACEUTICALS INC | — | 13,962 | $1.05M | 0.71% |
| 48 | GLOBUS MEDICAL INC | — | 11,395 | $981.79K | 0.66% |
| 49 | STERIS PLC | — | 4,309 | $952.85K | 0.64% |
| 50 | LABCORP HOLDINGS INC | — | 3,544 | $945.57K | 0.64% |
1 / 2
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.